Jennifer M. Denbow

Spearheaded by the biotechnology industry, non-invasive prenatal tests (NIPTs) hit the market in the United States in 2011. NIPTs have been rolled out with little public deliberation, yet they raise a number of complex political and ethical questions concerning disability, human welfare, and who should control the future of reproduction. This project examines how a preoccupation with innovation across financial, legal, and medical domains has contributed to the shrinking of public space for deliberation about this and other biotechnologies in the United States. This grant will support the manuscript’s development during the summer.